These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25041184)

  • 1. Red blood cells of sickle cell disease patients exhibit abnormally high abundance of N-methyl D-aspartate receptors mediating excessive calcium uptake.
    Hänggi P; Makhro A; Gassmann M; Schmugge M; Goede JS; Speer O; Bogdanova A
    Br J Haematol; 2014 Oct; 167(2):252-64. PubMed ID: 25041184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-methyl-D-aspartate receptors in human erythroid precursor cells and in circulating red blood cells contribute to the intracellular calcium regulation.
    Makhro A; Hänggi P; Goede JS; Wang J; Brüggemann A; Gassmann M; Schmugge M; Kaestner L; Speer O; Bogdanova A
    Am J Physiol Cell Physiol; 2013 Dec; 305(11):C1123-38. PubMed ID: 24048732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional plasticity of the N-methyl-d-aspartate receptor in differentiating human erythroid precursor cells.
    Hänggi P; Telezhkin V; Kemp PJ; Schmugge M; Gassmann M; Goede JS; Speer O; Bogdanova A
    Am J Physiol Cell Physiol; 2015 Jun; 308(12):C993-C1007. PubMed ID: 25788577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex Vivo Activation of Red Blood Cell Senescence by Plasma from Sickle-Cell Disease Patients: Correlation between Markers and Adhesion Consequences during Acute Disease Events.
    Chadebech P; Bodivit G; Di Liberto G; Jouard A; Vasseur C; Pirenne F; Bartolucci P
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34208829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of N-methyl D-aspartate (NMDA) receptors has no influence on rheological properties of erythrocytes.
    Reinhart WH; Geissmann-Ott C; Bogdanova A
    Clin Hemorheol Microcirc; 2011; 49(1-4):307-13. PubMed ID: 22214702
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Kalev-Zylinska ML; Hearn JI; Makhro A; Bogdanova A
    Front Physiol; 2020; 11():577. PubMed ID: 32625106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 5-hydroxymethyl-2-furfural on the volume and membrane permeability of red blood cells from patients with sickle cell disease.
    Hannemann A; Cytlak UM; Rees DC; Tewari S; Gibson JS
    J Physiol; 2014 Sep; 592(18):4039-49. PubMed ID: 25015917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional NMDA receptors in rat erythrocytes.
    Makhro A; Wang J; Vogel J; Boldyrev AA; Gassmann M; Kaestner L; Bogdanova A
    Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1315-25. PubMed ID: 20457837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic Acid-Activated Calcium Signaling Is Elevated in Red Cells from Sickle Cell Disease Patients.
    Wang J; Hertz L; Ruppenthal S; El Nemer W; Connes P; Goede JS; Bogdanova A; Birnbaumer L; Kaestner L
    Cells; 2021 Feb; 10(2):. PubMed ID: 33672679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte adhesion is modified by alterations in cellular tonicity and volume.
    Wandersee NJ; Punzalan RC; Rettig MP; Kennedy MD; Pajewski NM; Sabina RL; Paul Scott J; Low PS; Hillery CA
    Br J Haematol; 2005 Nov; 131(3):366-77. PubMed ID: 16225657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants.
    Amer J; Ghoti H; Rachmilewitz E; Koren A; Levin C; Fibach E
    Br J Haematol; 2006 Jan; 132(1):108-13. PubMed ID: 16371026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
    Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
    Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oxidative stress on red blood cell rheology in sickle cell patients.
    Hierso R; Waltz X; Mora P; Romana M; Lemonne N; Connes P; Hardy-Dessources MD
    Br J Haematol; 2014 Aug; 166(4):601-6. PubMed ID: 24754710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea.
    Cartron JP; Elion J
    Transfus Clin Biol; 2008; 15(1-2):39-50. PubMed ID: 18515167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
    Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
    Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of calpain-1 prevents red cell dehydration and reduces Gardos channel activity in a mouse model of sickle cell disease.
    De Franceschi L; Franco RS; Bertoldi M; Brugnara C; Matté A; Siciliano A; Wieschhaus AJ; Chishti AH; Joiner CH
    FASEB J; 2013 Feb; 27(2):750-9. PubMed ID: 23085996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
    Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal permeability pathways in human red blood cells.
    Ellory JC; Robinson HC; Browning JA; Stewart GW; Gehl KA; Gibson JS
    Blood Cells Mol Dis; 2007; 39(1):1-6. PubMed ID: 17434766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte and plasma oxidative stress appears to be compensated in patients with sickle cell disease during a period of relative health, despite the presence of known oxidative agents.
    Detterich JA; Liu H; Suriany S; Kato RM; Chalacheva P; Tedla B; Shah PM; Khoo MC; Wood JC; Coates TD; Milne GL; Oh JY; Patel RP; Forman HJ
    Free Radic Biol Med; 2019 Sep; 141():408-415. PubMed ID: 31279092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.